Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region
Go back to Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 197.90 +1.32 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $196.58 | 52 Week High | $333.65 | |||
| Open | $199.48 | 52 Week Low | $223.02 | |||
| Day High | $200.98 | P/E | 25.34 | |||
| Day Low | $194.74 | EPS | $7.81 | |||
| Volume | 369,953 | |||||
